KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Non-Current Assets (2016 - 2026)

Supernus Pharmaceuticals has reported Non-Current Assets over the past 15 years, most recently at $808.5 million for Q4 2025.

  • Quarterly Non-Current Assets rose 18.54% to $808.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.9 billion through Dec 2025, up 2.38% year-over-year, with the annual reading at $808.5 million for FY2025, 18.54% up from the prior year.
  • Non-Current Assets was $808.5 million for Q4 2025 at Supernus Pharmaceuticals, down from $825.9 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $1.1 billion in Q4 2021 and troughed at $643.5 million in Q2 2025.
  • The 5-year median for Non-Current Assets is $852.7 million (2023), against an average of $858.7 million.
  • Year-over-year, Non-Current Assets soared 45.61% in 2021 and then decreased 18.98% in 2023.
  • A 5-year view of Non-Current Assets shows it stood at $1.1 billion in 2021, then fell by 10.96% to $968.4 million in 2022, then fell by 18.98% to $784.6 million in 2023, then fell by 13.07% to $682.0 million in 2024, then grew by 18.54% to $808.5 million in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Non-Current Assets are $808.5 million (Q4 2025), $825.9 million (Q3 2025), and $643.5 million (Q2 2025).